Advanced search
Publication Cover
Expert Review of Cardiovascular Therapy Volume 16, 2018 - Issue 9
Submit an article Journal homepage
413
Views
0
CrossRef citations to date
0
Altmetric
Review

Antithrombotic strategies after interventional left atrial appendage closure: an update

Shaojie ChenCardioangiologisches Centrum Bethanien (CCB) Frankfurt am Main, Frankfurt am Main, GermanyView further author information
,
Felix K. WeiseCardioangiologisches Centrum Bethanien (CCB) Frankfurt am Main, Frankfurt am Main, GermanyView further author information
,
K. R. Julian ChunCardioangiologisches Centrum Bethanien (CCB) Frankfurt am Main, Frankfurt am Main, GermanyView further author information
&
Boris SchmidtCardioangiologisches Centrum Bethanien (CCB) Frankfurt am Main, Frankfurt am Main, GermanyCorrespondence[email protected]
View further author information
Pages 675-678 | Received 02 Apr 2018, Accepted 06 Aug 2018, Published online: 29 Aug 2018

References

  • Meier B, Blaauw Y, Khattab AA, et al. Document Reviewers. EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion. Europace. 2014 Oct;16(10):1397–1416.
  • Tzikas A, Holmes DR Jr, Gafoor S, et al. Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints and data collection requirements for clinical studies. EuroIntervention. 2016 May 17;12(1):103–111.
  • Holmes DR, Reddy VY, Turi ZG, et al. PROTECT AF Investigators. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009 Aug 15;374(9689):534–542.
  • Reddy VY, Möbius-Winkler S, Miller MA, et al. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix feasibility study with watchman left atrial appendage closure technology). J Am Coll Cardiol. 2013 Jun 25;61(25):2551–2556.
  • Holmes DR Jr, Kar S, Price MJ, et al. Prospective randomized evaluation of the watchman left atrial appendage closure device in patients with atrial fibrillation versus long-term warfarin therapy: the PREVAIL trial. J Am Coll Cardiol. 2014 Jul 8;64(1):1–12.
  • Boersma LV, Schmidt B, Betts TR; EWOLUTION investigators. et al. Implant success and safety of left atrial appendage closure with the WATCHMAN device: peri-procedural outcomes from the EWOLUTION registry. Eur Heart J. 2016 Aug;37(31):2465–2474.
  • Reddy VY, Gibson DN, Kar S, et al. Post-Approval U.S. Experience with left atrial appendage closure for stroke prevention in atrial fibrillation. J Am Coll Cardiol. 2017 Jan 24;69(3):253–261.
  • Bergmann MW, Ince H, Kische S, et al. Real world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy Results of the DAPT subgroup from the EWOLUTION all-comers study. EuroIntervention. 2018 Jan 9:EIJ-D-17–00672. [Epub ahead of print]. DOI:10.4244/EIJ-D-17-00672
  • Weise FK, Bordignon S, Perrotta L, et al. Short-term dual antiplatelet therapy after interventional left atrial appendage closure with different devices. EuroIntervention. 2018 Feb 6:EIJ-D-17–00901. [Epub ahead of print]. DOI:10.4244/EIJ-D-17-00901
  • Pracon R, Bangalore S, Dzielinska Z, et al. Device thrombosis after percutaneous left atrial appendage occlusion is related to patient and procedural characteristics but not to duration of postimplantation dual antiplatelet therapy. Circ Cardiovasc Interv. 2018 Mar;11(3):e005997.
  • Tzikas A, Shakir S, Gafoor S, et al. Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. EuroIntervention. 2016 Feb;11(10):1170–1179.
  • Landmesser U, Schmidt B, Nielsen-Kudsk JE, et al. Left atrial appendage occlusion with the AMPLATZER Amulet device: periprocedural and early clinical/echocardiographic data from a global prospective observational study. EuroIntervention. 2017 Sep 20;13(7):867–876.
  • Korsholm K, Nielsen KM, Jensen JM, et al. Transcatheter left atrial appendage occlusion in patients with atrial fibrillation and a high bleeding risk using aspirin alone for post-implant antithrombotic therapy. EuroIntervention. 2017 Apr 20;12(17):2075–2082.
  • Chen S, Schmidt B, Bordignon S, et al. Feasibility of percutaneous left atrial appendage closure using a novel LAmbre occluder in patients with atrial fibrillation: initial results from a prospective cohort registry study. J Cardiovasc Electrophysiol. 2018 Feb;29(2):291–297.
  • Huang H, Liu Y, Xu Y, et al. Percutaneous left atrial appendage closure with the LAmbre device for stroke prevention in atrial fibrillation: a prospective, multicenter clinical study. JACC Cardiovasc Interv. 2017 Nov 13; 10(21):2188–2194.
  • Schmidt B, Chun KR. Antithrombotic therapy after left atrial appendage closure. Expert Rev Cardiovasc Ther. 2015 Jan;13(1):105–109.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.